| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/22/2004 | US20040077596 Use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for suppressing side-effect of radiotherapy and chemotherapy |
| 04/22/2004 | US20040077595 Cyclodextrin-based polymers for therapeutics delivery |
| 04/22/2004 | US20040077561 Using 4-desacetyl-4-methylcarbonate taxol with doxorubicin; does not stimulate formation of cardiotoxic metabolic by products |
| 04/22/2004 | US20040077550 One pot process; forming acryloyl-guanidino derivatives |
| 04/22/2004 | US20040077540 Permeabilizing peptide; reversibly enhancing paracellular transport; inhibits homotypic binding |
| 04/22/2004 | US20040077535 Novel physiologically active peptide and use thereof |
| 04/22/2004 | US20040077532 Aglyco products and methods of use |
| 04/22/2004 | US20040077531 Regulating luteotropic hormone secretion; amino acid sequence 35 |
| 04/22/2004 | US20040077079 Methods, kits and production plant for use in the production of cell colony forming units from a mammalian tissue explant and to the use of cells from such cell colony forming units in treatment of mammals suffering from tissue disorders |
| 04/22/2004 | US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 04/22/2004 | US20040077045 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA) |
| 04/22/2004 | US20040077030 Methods and kits for detecting protein kinases |
| 04/22/2004 | US20040077029 Human protooncogene and protein encoded therein |
| 04/22/2004 | US20040077009 Human cyclin-dependent kinase (hPNQALRE) |
| 04/22/2004 | US20040077007 Human SMN-like protein |
| 04/22/2004 | US20040077000 Using cynomologous monkey P-glycoprotein nucleic acids and polypeptides in determining bioavailability of drugs and for screening for inhibitors of cynomologous P-glycoprotein |
| 04/22/2004 | US20040076997 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18 |
| 04/22/2004 | US20040076956 Oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genes associated with DNA repair which are directed against the sequence; ascertaining genetic and/ or epigenetic parameters of DNA repair genes |
| 04/22/2004 | US20040076955 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 04/22/2004 | US20040076683 Can be used for treatment of solid or circulating cancerous tumors; exhibit reduced toxicity compared to free drug in solution, exhibit stealth properties with respect to immune system of host to which they are administered |
| 04/22/2004 | US20040076680 Obtained by means of physico-chemical crosslinking of the derivatives of high-molecular-weight hyaluronic acid or salts thereof; antiarthritic agents |
| 04/22/2004 | US20040076679 Gel delivery vehicles for anticellular proliferative agents |
| 04/22/2004 | US20040076676 Heat-melting polylactic acid having a weight-average molecular weight of 3,000-40,000 at 140-220 degrees C, cooling, pulverizing solidified polylactic acid, adding active materials, compressing powder in mold |
| 04/22/2004 | US20040076672 For treating cancer and other angiogenic-dependent diseases, and more specifically, to compositions comprising anti-angiogenic factors and polymeric carriers, stents which have been coated with such compositions |
| 04/22/2004 | US20040076646 Stimulating the immune system of a host to mount an attack on tumor cells and/or antigens |
| 04/22/2004 | US20040076622 Local production and/or delivery of anti-cancer agents by stromal cell precursors |
| 04/22/2004 | US20040076614 For natural cellular immune defense in humans/animals; for foods/feeds |
| 04/22/2004 | US20040076608 Cytokine uses; compositions; methods |
| 04/22/2004 | US20040076581 For diagnosis/treatment of breast cancer, ovarian cancer, and glioblastomas; kits |
| 04/22/2004 | US20040076580 For diagnosis/treatment of thrombosis, embolism, atherosclerosis, inflammation or cancer; imaging |
| 04/22/2004 | DE10246890A1 New C-(imidazo-(1,2-a)-pyridin-3-yl)-methylamines, are nitrogen monoxide synthase inhibitors useful e.g. for treating migraine, septic shock, neurodegenerative diseases, inflammatory pain or cancer |
| 04/22/2004 | DE10153346A1 Substituierte Indole Substituted indoles |
| 04/22/2004 | DE10085492T5 Antimonocytenaktivität von extrakten von Betelpfefferblättern Antimonocytenaktivität of extracts of Betelpfefferblättern |
| 04/22/2004 | CA2501938A1 Compounds, compositions, and methods |
| 04/22/2004 | CA2501834A1 5-substituted 7,9-difluoro-5h-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulators |
| 04/22/2004 | CA2501833A1 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5h-chromeno[3,4-f]quinolines as selective progesterone receptor modulator compounds |
| 04/22/2004 | CA2501742A1 Medicine comprising a thiourea for use as depigmenting agent or anti-mutagenic and anti-carcinogenic agent |
| 04/22/2004 | CA2501633A1 Recombinant adenoviral vectors and applications thereof |
| 04/22/2004 | CA2501520A1 Sulfonamides having antiangiogenic and anticancer activity |
| 04/22/2004 | CA2501240A1 Extract of the plant calotropis procera with anti-tumor and anti-poisonous activity |
| 04/22/2004 | CA2500906A1 Combination therapy with gemcitabine and zd6126 |
| 04/22/2004 | CA2500763A1 Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine |
| 04/22/2004 | CA2500385A1 Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor |
| 04/22/2004 | CA2465860A1 Methods and compositions for therapeutic use of rna interference |
| 04/21/2004 | EP1411124A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/21/2004 | EP1411118A1 CELL PROLIFERATION INHIBITORS CONTAINING ANTI−GLYPICAN 3 ANTIBODY |
| 04/21/2004 | EP1411064A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 04/21/2004 | EP1411057A1 [3,4-a:3,4-c]carbazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/21/2004 | EP1411049A1 Estrogen Agonists/Antagonists |
| 04/21/2004 | EP1411046A1 QUINOLINE DERIVATIVE AND QUINAZOLINE DERIVATIVE INHIBITING SELF−PHOSPHORYLATION OF HEPATOCYTUS PROLIFERATOR RECEPTOR, AND MEDICINAL COMPOSITION CONTAINING THE SAME |
| 04/21/2004 | EP1410807A1 Methods and compositions useful for inhibition of angiogenesis |
| 04/21/2004 | EP1410806A1 Remedies for mammary cancer |
| 04/21/2004 | EP1410805A1 Vaccine against HPV |
| 04/21/2004 | EP1410804A1 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 04/21/2004 | EP1410802A1 Cell death inducers for mast cells |
| 04/21/2004 | EP1410799A1 Methods and pharmaceutical compositions for inhibiting tumour cell growth |
| 04/21/2004 | EP1410796A2 New therapeutic uses for potassium channel openers |
| 04/21/2004 | EP1410040A2 Method for identifying substances which modulate interleukin 4 (il-4) signaling |
| 04/21/2004 | EP1410038A2 Assays for identifying modulators of rhomboid polypeptides |
| 04/21/2004 | EP1410035A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 04/21/2004 | EP1410022A2 Detection and treatment of prostate cancer |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1410013A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer |
| 04/21/2004 | EP1409737A2 Methods for detecting and treating the early onset of aging-related conditions |
| 04/21/2004 | EP1409715A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | EP1409701A2 Fluorescently labelled locked nucleic acids |
| 04/21/2004 | EP1409699A1 Recombinant vectors derived from adeno-associated virus expressing tam67 for gene therapy |
| 04/21/2004 | EP1409680A2 Novel human proton-gated channels |
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
| 04/21/2004 | EP1409675A1 Gene involved in apoptosis regulation |
| 04/21/2004 | EP1409673A2 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 04/21/2004 | EP1409672A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 04/21/2004 | EP1409670A2 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression |
| 04/21/2004 | EP1409668A2 Antisense nucleic acid against alphav integrin |
| 04/21/2004 | EP1409661A2 Hdac9 polypeptides and polynucleotides and uses thereof |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409653A1 Viral mutants that selectively replicate in targeted human cancer cells |
| 04/21/2004 | EP1409648A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions |
| 04/21/2004 | EP1409645A1 Probiotic lactobacillus salivarius strains |
| 04/21/2004 | EP1409644A1 Probiotic bifidobacterium strains |
| 04/21/2004 | EP1409643A1 Probiotic lactobacillus casei strains |
| 04/21/2004 | EP1409639A1 Epidermal growth factor receptorantisense oligonucleotides |
| 04/21/2004 | EP1409550A1 Extracellular messengers |
| 04/21/2004 | EP1409549A2 Compositions and methods for the diagnosis and treatment of tumor |
| 04/21/2004 | EP1409547A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 04/21/2004 | EP1409544A2 Human dr4 antibodies and uses thereof |
| 04/21/2004 | EP1409540A2 Melanocortin receptor ligands |
| 04/21/2004 | EP1409539A1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409531A2 Heterocarpine, a human ghrh-binding protein |
| 04/21/2004 | EP1409526A2 An inducer of apoptosis |
| 04/21/2004 | EP1409525A2 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 04/21/2004 | EP1409523A2 Pancam nucleic acids and polypeptides |
| 04/21/2004 | EP1409520A2 Vegfr-3 inhibitor materials and methods |
| 04/21/2004 | EP1409519A1 Lipid-peptide conjugates for treatment of cancer |
| 04/21/2004 | EP1409516A2 Aromatic sulfenates for type i phototherapy |
| 04/21/2004 | EP1409502A2 Solvent-free anthracycline derivatives |
| 04/21/2004 | EP1409491A2 Thienopyrimidine-based inhibitors of the src family |
| 04/21/2004 | EP1409487A1 Pteridinones as kinase inhibitors |